Accordingly, Tang et al. have also explored the connection between CXCR7 and the stem-like phenotype of breast cancer cells, showing that shRNA-mediated inhibition of CXCR7 led to a reduction in CD44 expression and in other stem cell markers such as NANOG or ALDH1. Here, ACKR3 is linked to breast carcinoma.